Jul
2026
QSNCC, Bangkok, Thailand
Visit us
stand S51

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.

Exhibitor at CPHI South East Asia 2026
About Us

A leading High-end Pharmaceutical Injectables manufacturer from China with over 60 ANDAs approved in USA. Top 3 supplier of Heparin and Enoxaparin APIs across the globe. 
Top exporter from China to US of Injetables with over 250 Million USD revenue per year.
Two manufacturing sites for Injectables and one API manufacturing site accrediated with USFDA,  EMA, PMDA. 

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    2
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Pharmaceutical Company (generic finished products)
Contact info
  • (86-25) 86990701
  • 16 Xuefu Road,High&New Tech Development Zone, 21006, Nanjing, J.S., China
Show contact info Hide contact info
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand S51

Products Featured at CPHI South East Asia 2026

  • Heparin Sodium/ Enoxaparin Sodium

    Product Heparin Sodium/ Enoxaparin Sodium

    API and FDF both Approved in US, EU, China, Brazil US GMP, EU GMP, Japan GMP, China GMP, Brazil GMP, Mexico GMP available. World’s most stable supply, best quality, competitive price.